Northern Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $92.4M | Buy |
488,522
+11,651
| +2% | +$2.04M | 0.01% | 782 |
|
|
2025
Q4 | $81.1M | Sell |
476,871
-26,679
| -5% | -$4.09M | 0.01% | 826 |
|
|
2025
Q3 | $66.4M | Sell |
503,550
-222
| -0% | -$26.6K | 0.01% | 950 |
|
|
2025
Q2 | $53.5M | Sell |
503,772
-21,391
| -4% | -$2.32M | 0.01% | 1072 |
|
|
2025
Q1 | $65.2M | Buy |
525,163
+3,967
| +0.8% | +$518K | 0.01% | 927 |
|
|
2024
Q4 | $64.2M | Buy |
521,196
+82,817
| +19% | +$9.76M | 0.01% | 980 |
|
|
2024
Q3 | $48.8M | Sell |
438,379
-84,300
| -16% | -$9.24M | 0.01% | 1041 |
|
|
2024
Q2 | $55.8M | Sell |
522,679
-22,606
| -4% | -$2.49M | 0.01% | 934 |
|
|
2024
Q1 | $65.7M | Sell |
545,285
-63,634
| -10% | -$7.79M | 0.01% | 826 |
|
|
2023
Q4 | $74.9M | Sell |
608,919
-11,774
| -2% | -$1.47M | 0.01% | 750 |
|
|
2023
Q3 | $80.3M | Buy |
620,693
+46,830
| +8% | +$6.24M | 0.02% | 677 |
|
|
2023
Q2 | $71.1M | Sell |
573,863
-42,308
| -7% | -$5.69M | 0.01% | 744 |
|
|
2023
Q1 | $90.2M | Buy |
616,171
+16,321
| +3% | +$2.41M | 0.02% | 639 |
|
|
2022
Q4 | $95.6M | Sell |
599,850
-7,962
| -1% | -$1.17M | 0.02% | 598 |
|
|
2022
Q3 | $81M | Buy |
607,812
+1,226
| +0.2% | +$186K | 0.02% | 623 |
|
|
2022
Q2 | $94.6M | Sell |
606,586
-7,439
| -1% | -$1.15M | 0.02% | 579 |
|
|
2022
Q1 | $95.6M | Sell |
614,025
-7,118
| -1% | -$1.03M | 0.02% | 654 |
|
|
2021
Q4 | $79.1M | Sell |
621,143
-10,688
| -2% | -$1.4M | 0.01% | 784 |
|
|
2021
Q3 | $82.3M | Buy |
631,831
+28,672
| +5% | +$4.33M | 0.01% | 757 |
|
|
2021
Q2 | $107M | Buy |
603,159
+35,795
| +6% | +$6.2M | 0.02% | 646 |
|
|
2021
Q1 | $93.3M | Buy |
567,364
+42,696
| +8% | +$7.03M | 0.02% | 702 |
|
|
2020
Q4 | $86.6M | Buy |
524,668
+2,772
| +0.5% | +$413K | 0.02% | 706 |
|
|
2020
Q3 | $74.4M | Buy |
521,896
+154,713
| +42% | +$19.2M | 0.02% | 685 |
|
|
2020
Q2 | $40.5M | Sell |
367,183
-14,140
| -4% | -$1.56M | 0.01% | 1049 |
|
|
2020
Q1 | $38M | Sell |
381,323
-1,855
| -0.5% | -$240K | 0.01% | 945 |
|
|
2019
Q4 | $57.2M | Sell |
383,178
-74,681
| -16% | -$10.2M | 0.01% | 923 |
|
|
2019
Q3 | $58.7M | Buy |
457,859
+41,160
| +10% | +$5.52M | 0.01% | 857 |
|
|
2019
Q2 | $59.4M | Buy |
416,699
+7,723
| +2% | +$1.04M | 0.01% | 876 |
|
|
2019
Q1 | $58.5M | Buy |
408,976
+22,890
| +6% | +$2.99M | 0.01% | 846 |
|
|
2018
Q4 | $47.9M | Buy |
386,086
+31,303
| +9% | +$4.64M | 0.01% | 891 |
|
|
2018
Q3 | $59.6M | Buy |
354,783
+2,230
| +0.6% | +$384K | 0.01% | 855 |
|
|
2018
Q2 | $60.7M | Buy |
352,553
+120,736
| +52% | +$19.7M | 0.02% | 838 |
|
|
2018
Q1 | $35M | Buy |
231,817
+12,252
| +6% | +$1.8M | 0.01% | 1274 |
|
|
2017
Q4 | $29.6M | Sell |
219,565
-2,361
| -1% | -$327K | 0.01% | 1405 |
|
|
2017
Q3 | $32.5M | Buy |
221,926
+229
| +0.1% | +$34.6K | 0.01% | 1320 |
|
|
2017
Q2 | $34.5M | Buy |
221,697
+3,396
| +2% | +$519K | 0.01% | 1244 |
|
|
2017
Q1 | $31.7M | Buy |
218,301
+5,398
| +3% | +$703K | 0.01% | 1293 |
|
|
2016
Q4 | $23.2M | Sell |
212,903
-7,082
| -3% | -$789K | 0.01% | 1496 |
|
|
2016
Q3 | $26.7M | Sell |
219,985
-23,896
| -10% | -$3.22M | 0.01% | 1345 |
|
|
2016
Q2 | $34.5M | Sell |
243,881
-112,478
| -32% | -$16.6M | 0.01% | 1067 |
|
|
2016
Q1 | $46.7M | Sell |
356,359
-52,778
| -13% | -$6.57M | 0.02% | 851 |
|
|
2015
Q4 | $57.5M | Buy |
409,137
+8,331
| +2% | +$1.15M | 0.02% | 710 |
|
|
2015
Q3 | $53.2M | Buy |
400,806
+9,148
| +2% | +$1.58M | 0.02% | 761 |
|
|
2015
Q2 | $69M | Sell |
391,658
-72,987
| -16% | -$13.1M | 0.02% | 663 |
|
|
2015
Q1 | $80.3M | Buy |
464,645
+91,071
| +24% | +$15.6M | 0.02% | 607 |
|
|
2014
Q4 | $61.2M | Buy |
373,574
+107,718
| +41% | +$17.9M | 0.02% | 707 |
|
|
2014
Q3 | $42.7M | Buy |
265,856
+25,887
| +11% | +$3.98M | 0.01% | 905 |
|
|
2014
Q2 | $35.3M | Buy |
239,969
+29,700
| +14% | +$4.12M | 0.01% | 1064 |
|
|
2014
Q1 | $29.2M | Sell |
210,269
-35,794
| -15% | -$5.39M | 0.01% | 1253 |
|
|
2013
Q4 | $31.1M | Sell |
246,063
-29,971
| -11% | -$3.1M | 0.01% | 1142 |
|
|
2013
Q3 | $25.4M | Sell |
276,034
-270,370
| -49% | -$21.8M | 0.01% | 1259 |
|
|
2013
Q2 | $37.6M | Buy |
+546,404
| New | +$33.4M | 0.01% | 865 |
|
Other funds holding JAZZ
VPM
VCM
EC
Northern Trust's JAZZ Position: Q1 2026 in Review
Northern Trust increased its Jazz Pharmaceuticals (JAZZ) stake by 2.4% in Q1 2026, buying an estimated $2.04M and bringing the position to 488,522 shares worth $92.4M. The position accounts for 0.01% of the portfolio, ranked #782.
Northern Trust first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $107M in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Northern Trust held 488,522 shares of Jazz Pharmaceuticals worth $92.4M as of Q1 2026.
- Northern Trust bought 11,651 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.04M.
- Jazz Pharmaceuticals made up 0.01% of Northern Trust's portfolio in Q1 2026, its #782 holding.
- Northern Trust first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Jazz Pharmaceuticals position peaked at $107M in Q2 2021.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.